Biotech & Medtech
Biotech & Medtech news — Monday 12 October 2026
31 stories from 4 sources, every one in English. Each links to its publisher.
-
First Tracks climbs on ‘impressive’ celiac study data
BioPharma Dive
Initial study findings strengthened some analysts’ belief that First Tracks’ drug, one of a few in development aimed at the protein CD122, might have “pipeline-in-a-product” potential.
-
Parkinson’s cell therapy developer files to go public
BioPharma Dive
Aspen Neuroscience is looking to join the Nasdaq and raise more money to support its lead program, which aims to turn a patient's own cells into dopamine-producing neurons.
-
Bristol Myers dips on ‘confounding’ lung drug results
BioPharma Dive
Only the lower of two tested doses of the idiopathic pulmonary fibrosis drug admilparant met the trial’s main objective, adding to analyst questions about the therapy’s prospects.
-
Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug
MedCity News
Asahi Kasei’s Hovilpri is now approved for treating lesions caused by herpes simplex virus infection. This daily pill came from the $919 million acquisition of AiCuris Anti-Infective Cures. The post Asahi Kasei Acquisition Pays Off With…
-
Outro Raises $7M To Support Safe Deprescribing
MedCity News
Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group and Pave Health Ventures. The post Outro Raises $7M To Support…
-
Pediatric Innovation Isn’t a Small-Market Problem, It’s an Incentive Problem
MedCity News
Investing in pediatric care is not simply a moral imperative. It is one of the most practical long-term investments the healthcare system can make. The post Pediatric Innovation Isn’t a Small-Market Problem, It’s an Incentive Problem…
-
Loneliness And Diabetes: Harnessing an Opportunity for Better Outcomes
MedCity News
Asking the right questions about community support, caregiving responsibilities, emotional well-being, and the availability of trusted social networks can establish important context for a person’s outcomes — and spark conversations about…
-
Pharma’s $500B patent problem will come in waves — not as a cliff
BioPharma Dive
Merck is the most vulnerable to generic competition in the short term, but AbbVie, Johnson & Johnson, Sanofi and others will also grapple with patent losses in the years to come.
-
Join Us at INVEST Digital Health for a Conversation on Consumer-Centered Care across the Healthcare Ecosystem
MedCity News
Register for INVEST Digital Health, scheduled for October 29 in Dallas, for an engaging discussion on the impact of consumer-centered care from diagnostics to employer benefits and more. The post Join Us at INVEST Digital Health for a…
-
Bausch + Lomb swaps CEOs; Merck reveals anticipated eye drug data
BioPharma Dive
Bausch and Brent Saunders “mutually agreed” on his exit from the company, according to a statement. Elsewhere, Tezspire could have a new edge on Dupixent and a recent buyout deal paid dividends.
-
Are Hospital Operating Rooms Ready For FDA’s Expectations for Surgical Robots?
MedCity News
The FDA recently published draft guidance on pre-market testing for robotically-assisted surgical devices, raising timely discussion around whether hospital infrastructures are capable of supporting increasingly complex systems. The post…
-
EliteTable: Self-Improving Program Search for Executable Control Policies
arXiv cs.NE (Neural／Bio)
arXiv:2610.12536v1 Announce Type: cross Abstract: EliteTable is a self-improving program-search algorithm guided by large language models (LLMs) that uses a fixed-capacity table of high-scoring solutions to guide new proposals, edits of…
-
REMBGO for Evaluation-Limited Optimization: CEC2022 Benchmarking and EAF-STATCOM Generalization
arXiv cs.NE (Neural／Bio)
arXiv:2610.13471v1 Announce Type: new Abstract: Metaheuristic comparisons are often reported at evaluation budgets far larger than an expensive engineering simulation can afford. This paper presents REMBGO, an evaluation-budget-aware…
-
DyssomniaNN: Multi-Scale Spiking Neural Modeling of Human Sleep Disorders and Perceived Restedness
arXiv cs.NE (Neural／Bio)
arXiv:2610.13918v1 Announce Type: new Abstract: Clinical sleep medicine repeatedly documents profound divergences between objective sleep duration and subjective daytime impairment, notably exemplified by sleep state misperception in…
-
The value of information and the emergence of communication in evolved e-puck robots
arXiv cs.NE (Neural／Bio)
arXiv:2610.13118v1 Announce Type: cross Abstract: We study when communication emerges between autonomous agents and what role an innate action selection architecture plays. Two e-puck robots, reconstructed in PyBullet from their Webots…
-
Neuromorphic Satellite Intelligence: A Formal Framework for Event-Driven Architectures, Spike-Based Algorithms, and Quantitative Energy-Accuracy Trade-offs
arXiv cs.NE (Neural／Bio)
arXiv:2610.12471v1 Announce Type: new Abstract: Satellite onboard computing faces an irreducible tension: mission intelligence requirements grow monotonically while power, mass, and radiation budgets remain fixed. This paper advances the…
-
Energy-Efficient Spiking Neural Networks for Sensing-Aided Beam Prediction
arXiv cs.NE (Neural／Bio)
arXiv:2610.12507v1 Announce Type: new Abstract: Sensing-aided beam prediction can reduce the beam-training overhead of millimeter-wave (mmWave) systems by leveraging environmental information from complementary modalities such as vision…
-
Understanding Transformer-based Vision Models through Inversion
arXiv cs.NE (Neural／Bio)
arXiv:2412.06534v5 Announce Type: replace-cross Abstract: Understanding the internal mechanisms of deep neural networks remains a central challenge in machine learning. In computer vision, one promising yet only preliminarily explored…
-
Convex Optimization of Spiking Neural Networks with Global and Approximation Guarantees
arXiv cs.NE (Neural／Bio)
arXiv:2605.08022v3 Announce Type: replace Abstract: Spiking neural networks (SNNs) have been proposed as energy-efficient alternatives to deep neural networks. Their training is non-convex and involves a non-differentiable spike function…
-
A Multi-Agent LLM System for Automated Tuning of Specialized Neural Network Models
arXiv cs.NE (Neural／Bio)
arXiv:2610.13663v1 Announce Type: cross Abstract: Many machine learning approaches are two-level: an expert selects a class of methods, within this class the choice of key components is critical and usually manual. This paper addresses the…
-
Training Non-Differentiable Networks via Optimal Transport
arXiv cs.NE (Neural／Bio)
arXiv:2605.01928v4 Announce Type: replace-cross Abstract: Hard thresholds, quantization, and discrete routing can produce training losses with flat regions and jumps, where ordinary gradients vanish or are undefined. We introduce PolyStep…
-
Organisms Write Their Own Evolution: Direct Epigenomic Inheritance Accelerates Learning on Compositional Tasks
arXiv cs.NE (Neural／Bio)
arXiv:2602.00978v2 Announce Type: replace Abstract: What if organisms could write their own evolution? For 150 years, evolution has been understood as one-way: genes provide the rules, organisms respond to selection. But if organisms could…
-
Evolving Hybrid Quantum-Classical Architectures for Image Classification
arXiv cs.NE (Neural／Bio)
arXiv:2610.03220v2 Announce Type: replace Abstract: Hybrid quantum classical neural networks integrate parameterized quantum circuits (PQCs) with established deep learning architectures, but their performance depends strongly on the choice…
-
Five questions with Bowen Li
Nature Biotechnology
Nature Biotechnology, Published online: 12 October 2026; doi:10.1038/s41587-026-03340-9 A true multidisciplinary scientist, Bowen Li finds that some of the most interesting questions are located precisely at the boundaries between fields.
-
RevMed’s pancreatic cancer drug first
Nature Biotechnology
Nature Biotechnology, Published online: 12 October 2026; doi:10.1038/s41587-026-03363-2 RevMed’s pancreatic cancer drug first
-
FDA nod for rare neurology drug
Nature Biotechnology
Nature Biotechnology, Published online: 12 October 2026; doi:10.1038/s41587-026-03349-0 FDA nod for rare neurology drug
-
Live-cell imaging goes WHOLISTIC
Nature Biotechnology
Nature Biotechnology, Published online: 12 October 2026; doi:10.1038/s41587-026-03354-3 Live-cell imaging goes WHOLISTIC
-
Tracing the origins of CRISPR–Cas
Nature Biotechnology
Nature Biotechnology, Published online: 12 October 2026; doi:10.1038/s41587-026-03353-4 Tracing the origins of CRISPR–Cas
-
Genome editing
Nature Biotechnology
Nature Biotechnology, Published online: 12 October 2026; doi:10.1038/s41587-026-03324-9 Recent patents relating to systems, methods and compositions for use in genome editing.
-
Engrafting human cortical organoids
Nature Biotechnology
Nature Biotechnology, Published online: 12 October 2026; doi:10.1038/s41587-026-03355-2 Engrafting human cortical organoids
-
Biotech news from around the world
Nature Biotechnology
Nature Biotechnology, Published online: 12 October 2026; doi:10.1038/s41587-026-03347-2 Biotech news from around the world